Lincoln Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

580.55

510.31

472.08

413.06

376.09

Operating profit

99.91

89.17

95.47

81.35

59.37

Interest

1.46

2.03

1.45

1.44

1.98

Gross profit

132.87

109.62

104.02

86.68

69.52

EPS (Rs)

46.58

36.40

34.63

30.20

24.78

Other income

34.42

22.48

10.00

6.77

12.13

Stock adjustment

-5.70

-4.24

-13.57

1.35

-5.86

Raw material

201.12

177.00

158.48

95.50

101.97

Power and fuel

-

-

-

-

-

Employee expenses

102.90

93.16

70.47

56.47

54.90

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

182.32

155.23

161.23

178.39

165.71

Provisions made

-

-

-

-

-

Depreciation

10.62

9.17

8.09

5.67

5.47

Taxation

28.94

27.56

26.57

20.61

14.48

Net profit / loss

93.30

72.90

69.36

60.41

49.56

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

20.03

20.03

20.03

20.00

20.00

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

17.21

17.47

20.22

19.69

15.79

GPM (%)

21.61

20.57

21.58

20.65

17.91

NPM (%)

15.17

13.68

14.39

14.39

12.77